AlphaMadera combines institutional-grade analytics, real-time market data, and AI research tools to help investors make smarter long-term decisions.
Explore the Platform →Built for investors who think in decades, not days.
To our valued customers, log in here >
Sales at global fast-fashion apparel retailer H&M Hennes & Mauritz fell by 10% in its fiscal first quarter as stores continued to be closed, but the company has steered a course to greater profitability during a period of cautious consumption. While the stock dropped by almost 6% at the market opening, it recovered to close down 2.2% (CEST).
Danielle Gilbert, Managing Director at Eldridge Capital Management breaks down the overlooked income strategy institutions have used for decades and how everyday investors can tap into it now.
US stock benchmarks face a rougher morning session in the US as optimism around US-Iran talks fades. The cautious rebound wasn't long, as expected after a consistent failure to see progress in the talks.
A traditional buy-low, sell-high strategy has struggled in recent years as momentum-driven markets reward winners, according to Trivariate Research.
Oil prices have surged since the conflict with Iran began, gasoline has jumped, and markets sold off sharply after the Fed's March decision to keep rates steady.
The Investment Committee debate how to trade this market with the Iran War uncertainty looming over stocks. They discuss whether higher volatility is the new normal.
President Trump holds a cabinet meeting and gives an update on the war in Iran.
Katie Stockton, founder and managing partner at Fairlead Strategies, joins 'Money Movers' to discuss the war in Iran, energy prices, and more.
Jim Cramer is calling out what he sees as unwarranted negativity on Wall Street.
April kicks off with a holiday-shortened week, with markets closed at the end of the week to observe Good Friday.
Energy's critical role in global economic output has been underestimated, with its S&P 500 weighting falling below 3% despite universal dependence. Current Middle East disruptions have removed over 10% of global oil production, tightening supply-demand margins and risking extreme price spikes.
The US and Israel's recent war on Iran has caused a massive surge in oil prices globally, and a lot of market uncertainty - especially in Asia. However, global markets seem not to have fully priced in this conflict's potential effects just yet.
The Federal Reserve's Board of Governors urged a judge to reject prosecutors' request that he reconsider his decision to quash subpoenas issued in a criminal investigation of Chair Jerome Powell. U.S. Attorney Jeanine Pirro's prosecutors say they are investigating Powell over cost overruns in renovations of the Fed's headquarters in Washington and his congressional testimony about that project.
My geopolitical read is that a narrow ceasefire is easier than a full settlement. The harder issues remain unresolved, especially the control of the Strait of Hormuz.
The war in Iran will hike US inflation to 4.2% this year if a historic oil supply disruption drags on and leaves a lasting impact on prices, possibly hammering economic growth, the OECD predicted in a new forecast.
Public listings have long been the preferred exit for FinTechs seeking new avenues to raise capital and, arguably, to enhance their visibility and reputations. And especially for payments firms, trading platforms and digital financial services providers, an initial public offering (IPO) offers more than funding.
President Donald Trump criticizes Federal Reserve Chair Jerome Powell over the Fed building renovation costs during a Cabinet meeting at the White House. -------- More on Bloomberg Television and Markets Like this video?
Bargain stocks are in areas of U.S.-Japan synergy. Industrial conglomerate Hitachi has a joint venture with General Electric, for instance.
President Donald Trump said Thursday that neither the spike in oil prices nor the slump in the stock market during the Iran war were as bad he had anticipated.
The market for weight loss drugs is exploding and patients may have several new options in coming years.
Sarepta Therapeutics shares surge 35% as early data from two siRNA therapies show strong target knockdown, safety and muscle delivery potential.
Did you buy DRVN common stock between May 9, 2023, and February 24, 202 6? Affected Driven Brands Holdings Inc. Investor Summary Who: Driven Brands Holdings Inc. (NASDAQ: DRVN) What: Securities fraud class action lawsuit filed Class Period: May 9, 2023, through February 24, 2026 Deadline to Seek Lead Plaintiff Status: May 8, 2026 Key Lawsuit Allegations: Material misstatements and/or omissions concerning the company's accounting and internal controls over financial report.
Investors are hoping follow-up trial data will validate Grail's Galleri test. The failure to meet a trial's primary endpoint could be due to how the trial was designed rather than the efficacy of the Galleri test.
Precigen maintains a Buy rating as Papzimeos' strong launch and FDA approval signal blockbuster potential, with Q1 revenues expected to exceed $18M. PGEN's management guides for cash flow breakeven in 2026, supported by robust payer acceptance and a Q1 revenue run rate over $70M. Scenario analysis yields a probability-weighted fair value of $6.13/share, over 50% above current levels, with a base case fair value of $7.01/share.
New York, New York--(Newsfile Corp. - March 26, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of Disc Medicine, Inc. (NASDAQ: IRON) resulting from allegations that Disc Medicine may have issued materially misleading business information to the investing public. SO WHAT: If you purchased Disc Medicine securities you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.
Thanks for the memory?
Victor Dergunov, The Financial Prophet, talks his 5 step plan - raising cash, rotating into gold miners, energy, and defensive sectors amid heightened market uncertainty. Gold miners like Barrick (GOLD), Newmont (NEM), Agnico Eagle (AEM), and Kinross (KGC) are attractive after major declines, despite near-term headwinds from interest rate expectations.
Tanger (SKT) could produce exceptional returns because of its solid growth attributes.
AAR (AIR) is well positioned to outperform the market, as it exhibits above-average growth in financials.
LOS ANGELES--(BUSINESS WIRE)--Glancy Prongay Wolke & Rotter LLP, a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of ADMA Biologics, Inc. (“ADMA” or the “Company”) (NASDAQ: ADMA) investors concerning the Company's possible violations of the federal securities laws. IF YOU ARE AN INVESTOR WHO LOST MONEY ON ADMA BIOLOGICS, INC. (ADMA), CLICK HERE TO INQUIRE ABOUT POTENTIALLY PURSUING CLAIMS TO RECOVER YOUR LOSS. What Happened? On.